|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weigelt B, Peterse JL and van't Veer LJ:
Breast cancer metastasis: Markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen J, Stass SA and Jiang F: MicroRNAs as
potential biomarkers in human solid tumors. Cancer Lett.
329:125–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piasecka D, Braun M, Kordek R, Sadej R and
Romanska H: MicroRNAs in regulation of triple-negative breast
cancer progression. J Cancer Res Clin Oncol. 144:1401–1411. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu W, Tan C, He Y, Zhang G, Xu Y and Tang
J: Functional miRNAs in breast cancer drug resistance. Onco Targets
Ther. 11:1529–1541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu ZH, Lin C, Liu CC, Jiang WW, Huang MZ,
Liu X and Guo WJ: MiR-616-3p promotes angiogenesis and EMT in
gastric cancer via the PTEN/AKT/mTOR pathway. Biochem Biophys Res
Commun. 501:1068–1073. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bai QL, Hu CW, Wang XR, Shang JX and Yin
GF: MiR-616 promotes proliferation and inhibits apoptosis in glioma
cells by suppressing expression of SOX7 via the Wnt signaling
pathway. Eur Rev Med Pharmacol Sci. 21:5630–5637. 2017.PubMed/NCBI
|
|
12
|
Wang D, Cao Q, Qu M, Xiao Z, Zhang M and
Di S: MicroRNA-616 promotes the growth and metastasis of non-small
cell lung cancer by targeting SOX7. Oncol Rep. 38:2078–2086. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang D, Zhou P, Wang W, Wang X, Li J, Sun
X and Zhang L: MicroRNA-616 promotes the migration, invasion and
epithelial-mesenchymal transition of HCC by targeting PTEN. Oncol
Rep. 35:366–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma S, Chan YP, Kwan PS, Lee TK, Yan M,
Tang KH, Ling MT, Vielkind JR, Guan XY and Chan KW: MicroRNA-616
induces androgen-independent growth of prostate cancer cells by
suppressing expression of tissue factor pathway inhibitor TFPI-2.
Cancer Res. 71:583–592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Z, Zhu J, Zhu Y and Wang J:
MicroRNA-616 promotes the progression of ovarian cancer by
targeting TIMP2. Oncol Rep. 39:2960–2968. 2018.PubMed/NCBI
|
|
16
|
Chien YC, Liu LC, Ye HY, Wu JY and Yu YL:
EZH2 promotes migration and invasion of triple-negative breast
cancer cells via regulating TIMP2-MMP-2/-9 pathway. Am J Cancer
Res. 8:422–434. 2018.PubMed/NCBI
|
|
17
|
Chao Y, Hu K, Wang X and Wang L:
MicroRNA-552 promotes migration and invasion of osteosarcoma
through targeting TIMP2. Biochem Biophys Res Commun. 511:63–68.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yin S, Zhang Q, Wang Y, Li S and Hu R:
MicroRNA-130a regulated by HPV18 E6 promotes proliferation and
invasion of cervical cancer cells by targeting TIMP2. Exp Ther Med.
17:2837–2846. 2019.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren F, Tang R, Zhang X, Madushi WM, Luo D,
Dang Y, Li Z, Wei K and Chen G: Overexpression of MMP family
members functions as prognostic biomarker for breast cancer
patients: A systematic review and meta-analysis. PLoS One.
10:e01355442015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tjomsland V, Pomianowska E, Aasrum M,
Sandnes D, Verbeke CS and Gladhaug IP: Profile of MMP and TIMP
expression in human pancreatic stellate cells: Regulation by IL-1α
and TGFβ and implications for migration of pancreatic cancer cells.
Neoplasia. 18:447–456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu L, Mao X, Shi P, He B, Xu K, Zhang S
and Wang J: MicroRNAs in the prognosis of triple-negative breast
cancer: A systematic review and meta-analysis. Medicine
(Baltimore). 96:e70852017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kurzawski M, Kaczmarek M, Kłysz M,
Malinowski D, Kazienko A, Kurzawa R and Droździk M: MMP2, MMP9 and
TIMP2 polymorphisms affect sperm parameters but not fertility in
Polish males. Andrologia. 49:2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim HJ, Park CI, Park BW, Lee HD and Jung
WH: Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal
carcinoma in situ and invasive ductal carcinoma of the breast.
Yonsei Med J. 47:333–342. 2006. View Article : Google Scholar : PubMed/NCBI
|
